nodes	percent_of_prediction	percent_of_DWPC	metapath
Melphalan—SLC7A5—Basigin interactions—MAG—Parkinson's disease	0.0804	0.139	CbGpPWpGaD
Melphalan—Chlorambucil—GSTP1—Parkinson's disease	0.0733	0.404	CrCbGaD
Melphalan—SLC22A3—Abacavir transmembrane transport—ABCB1—Parkinson's disease	0.0642	0.111	CbGpPWpGaD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—MERTK—Parkinson's disease	0.0466	0.0803	CbGpPWpGaD
Melphalan—SLC22A3—tongue—Parkinson's disease	0.0392	0.165	CbGeAlD
Melphalan—SLC22A3—Abacavir transport and metabolism—ABCB1—Parkinson's disease	0.0369	0.0636	CbGpPWpGaD
Melphalan—L-Tyrosine—TH—Parkinson's disease	0.0334	0.184	CrCbGaD
Melphalan—SLC22A3—Synaptic Vesicle Pathway—PARK7—Parkinson's disease	0.0306	0.0527	CbGpPWpGaD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—NQO1—Parkinson's disease	0.0271	0.0466	CbGpPWpGaD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—MAG—Parkinson's disease	0.0268	0.0461	CbGpPWpGaD
Melphalan—L-DOPA—DDC—Parkinson's disease	0.0267	0.147	CrCbGaD
Melphalan—SLC7A5—cardiovascular system—Parkinson's disease	0.0227	0.0953	CbGeAlD
Melphalan—L-Phenylalanine—TH—Parkinson's disease	0.0194	0.107	CrCbGaD
Melphalan—SLC7A5—medulla oblongata—Parkinson's disease	0.0194	0.0814	CbGeAlD
Melphalan—SLC22A3—Synaptic Vesicle Pathway—SLC18A2—Parkinson's disease	0.0191	0.0329	CbGpPWpGaD
Melphalan—SLC22A3—embryo—Parkinson's disease	0.0188	0.0791	CbGeAlD
Melphalan—SLC7A5—midbrain—Parkinson's disease	0.0177	0.0744	CbGeAlD
Melphalan—SLC7A5—spinal cord—Parkinson's disease	0.0173	0.0726	CbGeAlD
Melphalan—SLC7A5—head—Parkinson's disease	0.0154	0.0645	CbGeAlD
Melphalan—SLC7A5—nervous system—Parkinson's disease	0.0146	0.0612	CbGeAlD
Melphalan—SLC7A5—central nervous system—Parkinson's disease	0.014	0.0589	CbGeAlD
Melphalan—SLC7A5—cerebellum—Parkinson's disease	0.0137	0.0576	CbGeAlD
Melphalan—SLC7A5—Hemostasis—DOCK3—Parkinson's disease	0.0126	0.0218	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—MERTK—Parkinson's disease	0.0126	0.0218	CbGpPWpGaD
Melphalan—SLC22A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC18A2—Parkinson's disease	0.0114	0.0197	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—DGKQ—Parkinson's disease	0.0113	0.0194	CbGpPWpGaD
Melphalan—SLC7A5—brain—Parkinson's disease	0.0111	0.0468	CbGeAlD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—IL1B—Parkinson's disease	0.0109	0.0187	CbGpPWpGaD
Melphalan—SLC22A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—Parkinson's disease	0.0105	0.0181	CbGpPWpGaD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—SLC18A2—Parkinson's disease	0.0102	0.0175	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.00974	0.0168	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.00974	0.0168	CbGpPWpGaD
Melphalan—SLC22A3—head—Parkinson's disease	0.00953	0.04	CbGeAlD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—CP—Parkinson's disease	0.00936	0.0161	CbGpPWpGaD
Melphalan—SLC22A3—nervous system—Parkinson's disease	0.00903	0.038	CbGeAlD
Melphalan—SLC22A3—central nervous system—Parkinson's disease	0.0087	0.0366	CbGeAlD
Melphalan—L-DOPA—DRD3—Parkinson's disease	0.00832	0.0458	CrCbGaD
Melphalan—L-DOPA—DRD1—Parkinson's disease	0.00817	0.045	CrCbGaD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—TNF—Parkinson's disease	0.00789	0.0136	CbGpPWpGaD
Melphalan—SLC22A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Parkinson's disease	0.00748	0.0129	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—MAG—Parkinson's disease	0.00725	0.0125	CbGpPWpGaD
Melphalan—SLC22A3—brain—Parkinson's disease	0.00691	0.029	CbGeAlD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—SLC6A3—Parkinson's disease	0.00667	0.0115	CbGpPWpGaD
Melphalan—L-DOPA—DRD2—Parkinson's disease	0.00576	0.0317	CrCbGaD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—SLC18A2—Parkinson's disease	0.00518	0.00893	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.00517	0.00891	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.00496	0.00855	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.00496	0.00855	CbGpPWpGaD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—CP—Parkinson's disease	0.00477	0.00822	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—CP—Parkinson's disease	0.00476	0.0082	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—FGB—Parkinson's disease	0.00457	0.00788	CbGpPWpGaD
Melphalan—L-DOPA—CYP2D6—Parkinson's disease	0.00407	0.0224	CrCbGaD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—SLC6A3—Parkinson's disease	0.0034	0.00586	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—SOD1—Parkinson's disease	0.0034	0.00585	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.00339	0.00584	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.00326	0.00561	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—ABL1—Parkinson's disease	0.00324	0.00558	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—IGF2—Parkinson's disease	0.00323	0.00556	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—HGF—Parkinson's disease	0.00305	0.00525	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.00283	0.00488	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.00272	0.00468	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.00263	0.00454	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—ND3—Parkinson's disease	0.00261	0.00449	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—MCCC1—Parkinson's disease	0.00261	0.00449	CbGpPWpGaD
Melphalan—Ibuprofen—ABCB1—Parkinson's disease	0.00253	0.0139	CrCbGaD
Melphalan—SLC22A3—Metabolism—TALDO1—Parkinson's disease	0.00245	0.00423	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—OMD—Parkinson's disease	0.00245	0.00423	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—CP—Parkinson's disease	0.00242	0.00418	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—NDUFB11—Parkinson's disease	0.00232	0.00401	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—GCH1—Parkinson's disease	0.00222	0.00382	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—DBH—Parkinson's disease	0.00198	0.00341	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—FBP1—Parkinson's disease	0.00198	0.00341	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—GBA—Parkinson's disease	0.00198	0.00341	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.00173	0.00298	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.00166	0.00286	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—DDC—Parkinson's disease	0.00145	0.0025	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.00144	0.00248	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.00138	0.00238	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—GSTA4—Parkinson's disease	0.00137	0.00236	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PLA2G6—Parkinson's disease	0.00123	0.00213	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—MAOB—Parkinson's disease	0.00122	0.0021	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—CYP2D6—Parkinson's disease	0.000908	0.00156	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—CTGF—Parkinson's disease	0.000891	0.00153	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—CYP2E1—Parkinson's disease	0.00083	0.00143	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—NQO1—Parkinson's disease	0.000821	0.00141	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—TH—Parkinson's disease	0.000809	0.00139	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—CYCS—Parkinson's disease	0.000777	0.00134	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—COMT—Parkinson's disease	0.000688	0.00119	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—GSTP1—Parkinson's disease	0.000685	0.00118	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—MAOA—Parkinson's disease	0.000683	0.00118	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—HMOX1—Parkinson's disease	0.000675	0.00116	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—ABCB1—Parkinson's disease	0.000648	0.00112	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—GSTM1—Parkinson's disease	0.000629	0.00108	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—GPX1—Parkinson's disease	0.000602	0.00104	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—MTHFR—Parkinson's disease	0.000556	0.000958	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—APOE—Parkinson's disease	0.000518	0.000892	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—INS—Parkinson's disease	0.000442	0.000762	CbGpPWpGaD
